SCOPUS 정보 검색 플랫폼

Heart Rhythm

Volumn 1, Issue 4, 2004, Pages 516-518

Non-antiarrhythmic drugs to prevent atrial fibrillation

(3) Folkeringa, Richard J a Tieleman, Robert G a Crijns, Harry J G M a

a MAASTRICHT UNIVERSITY (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; AMIODARONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ATENOLOL; CARDIAC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LOSARTAN; PLACEBO; RAS PROTEIN; SPIRONOLACTONE; TRANDOLAPRIL; VALSARTAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE MODEL; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; HEART ARRHYTHMIA; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART PROTECTION; HUMAN; HYPERTENSION; INFLAMMATION; MYOCARDITIS; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIMARY PREVENTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SECONDARY PREVENTION; SIGNAL TRANSDUCTION;

EID: 7744220560 PISSN: 15475271 EISSN: None Source Type: Journal
DOI: 10.1016/j.hrthm.2004.02.019 Document Type: Note

Times cited : (7)

References (12)

1
- 0033529394
- Promotion of atrial fibrillation by heart failure in dogs. Atrial remodeling of a different sort
- D. Li S. Fareh T.K. Leung S. Nattel Promotion of atrial fibrillation by heart failure in dogs. Atrial remodeling of a different sort Circulation 100 1999 87-95
- (1999) Circulation , vol.100 , pp. 87-95
- Li, D.¹ Fareh, S.² Leung, T.K.³ Nattel, S.⁴

2
- 0034025839
- Increased expression of Extracellular Signal-regulated Kinase and Angiotensin-Converting Enzyme in human atria during atrial fibrillation
- A. Goette T. Staack C. Röcken M. Arndt C. Geller C. Huth S. Ansorge H.U. Klein U. Lendeckel Increased expression of Extracellular Signal-regulated Kinase and Angiotensin-Converting Enzyme in human atria during atrial fibrillation J Am Coll Cardiol 35 2000 1669-1677
- (2000) J. Am. Coll. Cardiol. , vol.35 , pp. 1669-1677
- Goette, A.¹ Staack, T.² Röcken, C.³ Arndt, M.⁴ Geller, C.⁵ Huth, C.⁶ Ansorge, S.⁷ Klein, H.U.⁸ Lendeckel, U.⁹

3
- 0034727695
- Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Insights from the randomized aldactone evaluation study (RALES)
- F. Zannad F. Alla B. Dousset A. Perez B. Pitt Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Insights from the randomized aldactone evaluation study (RALES) Circulation 102 2000 2700-2706
- (2000) Circulation , vol.102 , pp. 2700-2706
- Zannad, F.¹ Alla, F.² Dousset, B.³ Perez, A.⁴ Pitt, B.⁵

4
- 0034284485
- Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension
- S.F. Su C.L. Hsiao C.W. Chu B.C. Lee T.M. Lee Effects of pravastatin on left ventricular mass in patients with hyperlipidemia and essential hypertension Am J Cardiol 86 2000 514-518
- (2000) Am. J. Cardiol. , vol.86 , pp. 514-518
- Su, S.F.¹ Hsiao, C.L.² Chu, C.W.³ Lee, B.C.⁴ Lee, T.M.⁵

5
- 0034670114
- Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting
- M.I. Dotani M. Elnicki A.C. Jain C.M. Gibson Effect of preoperative statin therapy and cardiac outcomes after coronary artery bypass grafting Am J Cardiol 86 2000 1128-1130
- (2000) Am. J. Cardiol. , vol.86 , pp. 1128-1130
- Dotani, M.I.¹ Elnicki, M.² Jain, A.C.³ Gibson, C.M.⁴

6
- 3042752697
- Losartan reduces the risk of new onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: The LIFE study
- (abstract)
- K. Wachtell M. Lehto B. Hornestam E. Gerdts D. Slotwiner M.H. Olsen R.B. Devereux H. Ibsen S. Julius S.E. Kjeldsen L.H. Lindholm M.S. Nieminen B. Dalhöf Losartan reduces the risk of new onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: The LIFE study (abstract) Eur Heart J 24 2003 407
- (2003) Eur. Heart J. , vol.24 , pp. 407
- Wachtell, K.¹ Lehto, M.² Hornestam, B.³ Gerdts, E.⁴ Slotwiner, D.⁵ Olsen, M.H.⁶ Devereux, R.B.⁷ Ibsen, H.⁸ Julius, S.⁹ Kjeldsen, S.E.¹⁰ Lindholm, L.H.¹¹ Nieminen, M.S.¹² Dalhöf, B.¹³

7
- 0033609470
- Trandalopril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction
- O.D. Pedersen H. Bagger L. Kober C. Torp-Pedersen Trandalopril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation 100 1999 376-380
- (1999) Circulation , vol.100 , pp. 376-380
- Pedersen, O.D.¹ Bagger, H.² Kober, L.³ Torp-Pedersen, C.⁴

8
- 0038649984
- Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction. Insight from the studies of left ventricular dysfunction (SOLVD) trials
- E. Vermes J.C. Tardif M.G. Bourassa N. Racine S. Levesque M. White P.G. Guerra A. Ducharme Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction. Insight from the studies of left ventricular dysfunction (SOLVD) trials Circulation 107 2003 2926-2931
- (2003) Circulation , vol.107 , pp. 2926-2931
- Vermes, E.¹ Tardif, J.C.² Bourassa, M.G.³ Racine, N.⁴ Levesque, S.⁵ White, M.⁶ Guerra, P.G.⁷ Ducharme, A.⁸

9
- 7744237955
- Valsartan Heart Failure Trial (Val-HeFT)
- Presented at the ESC Congress 2003;August 30-September 3, 2003; Vienna, Austria. Clinical trial update II: Heart Failure (abstract)
- A.P. Maggioni R. Latini P.E. Carson S.N. Singh S. Barlera J.N. Cohn Valsartan Heart Failure Trial (Val-HeFT) Presented at the ESC Congress 2003;August 30-September 3, 2003; Vienna, Austria. Clinical trial update II: Heart Failure (abstract) Eur Heart J 24 2003 407
- (2003) Eur. Heart J. , vol.24 , pp. 407
- Maggioni, A.P.¹ Latini, R.² Carson, P.E.³ Singh, S.N.⁴ Barlera, S.⁵ Cohn, J.N.⁶

10
- 0037118662
- Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. A prospective and randomised study
- A.H. Madrid M.G. Bueno J.M.G. Rebollo I. Marin G. Pena E. Bernal A. Rodriguez L. Cano P. Cabeza C. Moro Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. A prospective and randomised study Circulation 106 2002 331-336
- (2002) Circulation , vol.106 , pp. 331-336
- Madrid, A.H.¹ Bueno, M.G.² Rebollo, J.M.G.³ Marin, I.⁴ Pena, G.⁵ Bernal, E.⁶ Rodriguez, A.⁷ Cano, L.⁸ Cabeza, P.⁹ Moro, C.¹⁰

11
- 6444240877
- Angiotensin-converting enzyme inhibition with trandolapril prevents recurrences of paroxysmal lone atrial fibrillation in normotensive patients
- abstract
- F. Belluzzi L. Sernesi C. Valenti F. Salvucci M. Vezzoli S. Perlini Angiotensin-converting enzyme inhibition with trandolapril prevents recurrences of paroxysmal lone atrial fibrillation in normotensive patients Eur Heart J 24 Suppl 407 2003 abstract 2162
- (2003) Eur. Heart J. , vol.24 , Issue.SUPPL. 407 , pp. 2162
- Belluzzi, F.¹ Sernesi, L.² Valenti, C.³ Salvucci, F.⁴ Vezzoli, M.⁵ Perlini, S.⁶

12
- 0030763103
- Histological substrate of atrial biopsies in patients with lone atrial fibrillation
- A. Frustaci C. Chimenti F. Bellocci E. Morgante M.A. Russo A. Maseri Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180-1184
- (1997) Circulation , vol.96 , pp. 1180-1184
- Frustaci, A.¹ Chimenti, C.² Bellocci, F.³ Morgante, E.⁴ Russo, M.A.⁵ Maseri, A.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.